MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
96 hedge funds and large institutions have $279M invested in Marinus Pharmaceuticals, Inc in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
32% more funds holding
Funds holding: 73 → 96 (+23)
21% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 19
Holders
96
Holding in Top 10
3
Calls
$18.3M
Puts
$8.28M
Top Buyers
| 1 | +$17.7M | |
| 2 | +$9M | |
| 3 | +$4.74M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.09M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.36M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$8.55M | |
| 3 | -$2.68M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.78M |
| 5 |
HT
HAP Trading
New York
|
-$1.54M |